drugset / Trial / NCT02224040

Typhoid Fever: Combined vs. Single Antibiotic Therapy

NCT02224040

Phase 4 Unknown 120 enrolled Sheba Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The current study goal is to examine the effect of Cephalosporins, Azithromycin and the combination of both on typhoid fever therapy in endemic population. The investigator's hypothesize that the combination of azithromycin and ceftriaxone may prove superior to each drug, ceftriaxone or azithromycin, alone.

Timeline

Start
2013-08
Primary completion
2014-12
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 20 mg/kg Oral
Subject Azithromycin Small molecule 500 mg Oral
Subject Cefixime Other / unclassified 10 mg/kg Oral
Subject Cefixime Other / unclassified 400 mg Oral
Subject Ceftriaxone Other / unclassified 75 mg/kg Intravenous
Subject Ceftriaxone Other / unclassified 2 g Intravenous

Indications